John Irwin is listed as a director on 3 SEC Form D filings by 1 issuer between Dec 2014 and Apr 2016: Mitochon Pharmaceuticals, Inc. (Radnor, PA — pharmaceuticals — 2014–2016; $425K reported sold to 5 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside John Geisler (3 shared filings), Peter Crooks (3 shared filings) and Robert Alonso (3 shared filings).
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around John. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — 5 SEC releases, 11 bankruptcy cases matching the name listed in Key records below.
What this means 16 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 3 public filings for John Irwin and found 9 differences, 1 worth asking the sponsor about: Regulator action: John N. Irwin, CPA (Jul 21, 2011); and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.